New York Life Investment Management »

Catalyst Pharmaceutical Partners shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 88k 31.43
2024-03-31 $361k 23k 15.94
2022-12-31 $1.3M 68k 18.60
2022-09-30 $784k 61k 12.83
2022-06-30 $394k 56k 7.00

More positions owned by New York Life Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
New York Life Investments Et Nyli Us Lc R&d L (LRND)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
New York Life Investments Et Candriam Us Mid (IQSM)
New York Life Investments Et Candriam Us Lrg (IQSU)
New York Life Invts Active E Mack Core Bd Etf (CPLB)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
New York Life Investments Et Candriam Intl Eq (IQSI)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Vanguard World Mega Cap Index (MGC)
Micron Technology (MU)

View all positions for New York Life Investment Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners